Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC) and Parkway Life Real Estate Investment (OtherPRKWF)
There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Healthpeak Properties (DOC – Research Report) and Parkway Life Real Estate Investment (PRKWF – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Healthpeak Properties (DOC)
Morgan Stanley analyst Ronald Kamdem maintained a Buy rating on Healthpeak Properties yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $16.45.
According to TipRanks.com, Kamdem is a 4-star analyst with an average return of
Healthpeak Properties has an analyst consensus of Moderate Buy, with a price target consensus of $19.25, a 16.7% upside from current levels. In a report released yesterday, Evercore ISI also maintained a Buy rating on the stock with a $22.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Parkway Life Real Estate Investment (PRKWF)
CGS International analyst Lock Mun Yee reiterated a Buy rating on Parkway Life Real Estate Investment today and set a price target of S$4.97. The company’s shares closed last Monday at $3.13.
According to TipRanks.com, Yee is a 3-star analyst with an average return of
Currently, the analyst consensus on Parkway Life Real Estate Investment is a Strong Buy with an average price target of $3.90, a 24.8% upside from current levels. In a report released yesterday, TipRanks – Google also upgraded the stock to Buy with a S$4.50 price target.
